Showing results (131-140 of 183) with videos related to

Sort By:
Pageof 19
Ebiomedicine|November 7, 2018
Salidroside improves the hypoxic tumor microenvironment and reverses the drug resistance of platinum drugs via HIF-1α signaling pathwayYuan Qin, Hui-Juan Liu, Meng Li, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|December 19, 2006
[Monitoring bcr-abl mRNA levels by real-time quantitative RT-PCR in chronic myeloid leukemia patients after hematopoietic stem cell transplantation]Ya-zhen Qin, Jin-lan Li, Hong-hu Zhu, et al.
Journal of Hematology & Oncology|June 12, 2012
Administration of imatinib after allogeneic hematopoietic stem cell transplantation may improve disease-free survival for patients with Philadelphia chromosome-positive acute lymphobla stic leukemiaHuan Chen, Kai-yan Liu, Lan-ping Xu, et al.
BMC Cancer|April 13, 2016
Prognostic impact of IKZF1 deletion in adults with common B-cell acute lymphoblastic leukemiaQiu-Mei Yao, Kai-Yan Liu, Robert Peter Gale, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi|April 22, 2009
[Expression of 5 genes in CD7 positive acute myeloid leukemia stem/progenitor cells from bone marrow]Hong-Hong Wu, Hui Cao, Ya-Zhe Wang, et al.
Oncogene|August 9, 2018
Hsp90β promotes aggressive vasculogenic mimicry via epithelial-mesenchymal transition in hepatocellular carcinomaJing Meng, Shuang Chen, Yue-Yang Lei, et al.
Zhonghua Yi Xue Za Zhi|January 13, 2006
[Analysis of ABL tyrosine kinase point mutations in imatinib treated chronic myelogenous leukemia patients]Ya-zhen Qin, Yan-rong Liu, Jin-lan Li, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 25, 2013
Association of an impaired bone marrow microenvironment with secondary poor graft function after allogeneic hematopoietic stem cell transplantationYuan Kong, Ying-Jun Chang, Ya-Zhe Wang, et al.
Journal of Experimental & Clinical Cancer Research : CR|August 8, 2018
Protease-activated receptor-1 (PAR1) promotes epithelial-endothelial transition through Twist1 in hepatocellular carcinomaTing Xiao, Qiang Zhang, Shumin Zong, et al.
Leukemia & Lymphoma|November 1, 2012
PRAME and WT1 transcripts constitute a good molecular marker combination for monitoring minimal residual disease in myelodysplastic syndromesYa-Zhen Qin, Hong-Hu Zhu, Yan-Rong Liu, et al.
Pageof 19